Showing results (171-180 of 824) with videos related to
Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2011
Disentangling the myeloma webGiovanni Tonon, Kenneth C AndersonHaematologica|October 15, 2020
Multiple myeloma: the (r)evolution of current therapy and a glance into futureAnnamaria Gulla, Kenneth C AndersonExpert Opinion on Drug Safety|February 27, 2020
The safety of current and emerging therapies for multiple myelomaOmar Nadeem, Kenneth C AndersonOncology (Williston Park, N.Y.)|June 7, 2005
Treatment options for older myeloma patients. From the Multiple Myeloma Research FoundationKenneth C Anderson, Antonio Palumbo, International Journal of Hematology|September 2, 2011
Novel therapies in MM: from the aspect of preclinical studiesTeru Hideshima, Kenneth C AndersonBlood|October 9, 2004
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsKlaus Podar, Kenneth C AndersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Synopsis of a roundtable on validating novel therapeutics for multiple myelomaWilliam Dalton, Kenneth C AndersonInternational Journal of Hematology|March 12, 2013
Histone deacetylase inhibitors in the treatment for multiple myelomaTeru Hideshima, Kenneth C AndersonBlood|May 7, 2009
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaMariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima, et al.Current Opinion in Oncology|November 1, 2002
Thalidomide and immunomodulatory drugs as cancer therapyNoopur Raje, Kenneth C AndersonPageof 83